Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02214069 · ClinicalTrials.gov registry record
Using Smart Phone Technology in Detecting the Presence of Atrial Fibrillation
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 60
- Enrollment target
NCT02214069: Completed study, sponsored by The Cleveland Clinic.
NCT02214069 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02214069 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether patients can use the AliveCor case to record their heart rhythm and to assess the accuracy of the software in detecting AF vs sinus rhythm
Primary Outcome
Both the software nd overreading electrophysiologist come to the same conclusion regarding the rhythm of the ECG and Alivecor reading. Both determining that the tracing is either normal sinus rhythm or atrial fibrillation.
Interventions
- DEVICE Record and transmit heart rhythm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-07 |
What the finished NCT02214069 record still lists
NCT02214069 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Record and transmit heart rhythm is the first listed.
NCT02214069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02214069 about?
NCT02214069 is a clinical study titled "Using Smart Phone Technology in Detecting the Presence of Atrial Fibrillation". The purpose of this study is to examine whether patients can use the AliveCor case to record their heart rhythm and to assess the accuracy of the software in detecting AF vs sinus rhythm
What is the current status of trial NCT02214069?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2014-08. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02214069?
The interventions under investigation include: Record and transmit heart rhythm (DEVICE).
Who is sponsoring clinical trial NCT02214069?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia